News

Fangzhou and Novo Nordisk link on chronic disease management
The joint effort will focus on providing patients with medication guidance, reminders, tracking of efficacy and health education.
HIMS SECURITIES NEWS: Did Hims & Hers Health, Inc. (NYSE:HIMS) Commit Securities Fraud? Contact BFA Law By August 25 Class Action Deadline
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Hims & Hers Health, Inc.
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
Is working out necessary in the age of Ozempic?
Fitness experts say using weight-loss drugs is just one piece of the puzzle for many attempting to live healthier ...